The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Mesothelin targeted cancer immunotherapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
Bast, R. C., Klug, T. L., John, E. S., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310133091503 · Cited by 2,135
Chang, K., & Pastan, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.136 · Cited by 745
Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways
Miller, J. R., Hocking, A. M., Brown, J. D., & Moon, R. T. (1999) · Oncogene · doi:10.1038/sj.onc.1203245 · Cited by 691
Molecular Cloning of the CA125 Ovarian Cancer Antigen
Yin, B. W. T., & Lloyd, K. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103554200 · Cited by 617
Jaffee, E. M., Hruban, R. H., Biedrzycki, B., Laheru, D., Schepers, K., Sauter, P. R., Goemann, M., Coleman, J., Grochow, L., Donehower, R. C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.145 · Cited by 600
Argani, P., Iacobuzio–Donahue, C. A., Ryu, B., Rosty, C., Goggins, M., Wilentz, R. E., Murugesan, S. R., Leach, S. D., Jaffee, E. M., Yeo, C. J., et al. (2001) · PubMed · Cited by 574
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
Rump, A., Morikawa, Y., Tanaka, M., Minami, S., Umesaki, N., Takeuchi, M., & Miyajima, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312372200 · Cited by 572
Mesothelin-family proteins and diagnosis of mesothelioma
Robinson, B. W., Creaney, J., Lake, R., Nowak, A., Musk, A. W., de Klerk, N., Winzell, P., Hellstrom, K. E., & Hellstrom, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14794-0 · Cited by 534
Pastan, I., Hassan, R., FitzGerald, D. J., & Kreitman, R. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1891 · Cited by 528
Self-citationHassan, R., Bera, T., & Pastan, I. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0801 · Cited by 441
Self-citationGubbels, J. A., Belisle, J., Onda, M., Rancourt, C., Migneault, M., Ho, M., Bera, T. K., Connor, J., Sathyanarayana, B. K., Lee, B., et al. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-50 · Cited by 422
Self-citationApplication of Mesothelin Immunostaining in Tumor Diagnosis
Ordóñez, N. G. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200311000-00003 · Cited by 382
Hassan, R., Bullock, S., Premkumar, A., Kreitman, R. J., Kindler, H., Willingham, M. C., & Pastan, I. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0869 · Cited by 379
Self-citationThomas, A. M., Santarsiero, L. M., Lutz, E. R., Armstrong, T. D., Chen, Y.-C., Huang, L.-Q., Laheru, D. A., Goggins, M., Hruban, R. H., & Jaffee, E. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031435 · Cited by 347
Listeria-based cancer vaccines that segregate immunogenicity from toxicity
Brockstedt, D. G., Giedlin, M. A., Leong, M. L., Bahjat, K. S., Gao, Y., Luckett, W., Liu, W., Cook, D. N., Portnoy, D. A., & Dubensky, T. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406035101 · Cited by 299
Hassan, R., Remaley, A. T., Sampson, M. L., Zhang, J., Cox, D. D., Pingpank, J., Alexander, R., Willingham, M., Pastan, I., & Onda, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1477 · Cited by 296
Self-citationChang, K., Pastan, I., & Willingham, M. C. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500308 · Cited by 271
Value of Mesothelin Immunostaining in the Diagnosis of Mesothelioma
Ordóñez, N. G. (2003) · Modern Pathology · doi:10.1097/01.mp.0000056981.16578.c3 · Cited by 259
Improving antibody affinity by mimicking somatic hypermutation in vitro
Chowdhury, P. S., & Pastan, I. (1999) · Nature Biotechnology · doi:10.1038/9872 · Cited by 256
Mesothelin Is Not Required for Normal Mouse Development or Reproduction
Bera, T. K., & Pastan, I. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2902-2906.2000 · Cited by 253
Hassan, R., Laszik, Z. G., Lerner, M., Raffeld, M., Postier, R., & Brackett, D. (2005) · American Journal of Clinical Pathology · doi:10.1309/f1b6-4cl7-h8vj-keaf · Cited by 236
Self-citationChowdhury, P. S., Viner, J. L., Beers, R., & Pastan, I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.669 · Cited by 222
Uematsu, K., Kanazawa, S., You, L., He, B., Xu, Z., Li, K., Peterlin, B. M., McCormick, F. P., & Jablons, D. M. (2003) · PubMed · Cited by 188
Localization of Mesothelin in Epithelial Ovarian Cancer
Hassan, R., Kreitman, R. J., Pastan, I., & Willingham, M. C. (2005) · Applied Immunohistochemistry & Molecular Morphology · doi:10.1097/01.pai.00000141545.36485.d6 · Cited by 178
Self-citationFrierson, H. F., Moskaluk, C. A., Powell, S. M., Zhang, H., Cerilli, L. A., Stoler, M. H., Cathro, H., & Hampton, G. M. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00177-1 · Cited by 171
Ordóñez, N. G. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.08.010 · Cited by 170
Mesothelin Expression in Human Lung Cancer
Ho, M., Bera, T. K., Willingham, M. C., Onda, M., Hassan, R., FitzGerald, D., & Pastan, I. H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2161 · Cited by 156
Self-citationHumoral Immune Response to Mesothelin in Mesothelioma and Ovarian Cancer Patients
Ho, M., Hassan, R., Zhang, J., Wang, Q., Onda, M., Bera, T. K., & Pastan, I. H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2304 · Cited by 149
Self-citationAnalysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays
Swierczynski, S. L., Maitra, A., Abraham, S. C., Iacobuzio–Donahue, C. A., Ashfaq, R., Cameron, J. L., Schulick, R. D., Yeo, C. J., Rahman, A., Hinkle, D. A., et al. (2004) · Human Pathology · doi:10.1016/j.humpath.2003.10.012 · Cited by 144
Diffuse Mesothelin Expression Correlates with Prolonged Patient Survival in Ovarian Serous Carcinoma
Yen, M. J., Hsu, C.-Y., Mao, T., Wu, T. ‐., Roden, R. B. S., Wang, T., & Shih, I. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1397 · Cited by 96
Prieve, M. G., & Moon, R. T. (2003) · BMC Developmental Biology · doi:10.1186/1471-213x-3-2 · Cited by 88
Synergistic Antitumor Activity of Taxol and Immunotoxin SS1P in Tumor-Bearing Mice
Zhang, Y., Xiang, L., Hassan, R., Paik, C. H., Carrasquillo, J. A., Jang, B., Le, N., Ho, M., & Pastan, I. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0346 · Cited by 75
Self-citationHassan, R., Lerner, M. R., Benbrook, D. M., Lightfoot, S. A., Brackett, D. J., Wang, Q.-C., & Pastan, I. H. (2002) · PubMed · Cited by 70
Self-citationLi, Q., Verschraegen, C. F., Mendoza, J. T., et al. (2004) · PubMed · Cited by 59
Cited by
Engineered T cells: the promise and challenges of cancer immunotherapy
Fesnak, A. D., June, C. H., & Levine, B. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.97 · Cited by 1,074
NK cell-based cancer immunotherapy: from basic biology to clinical development
Liu, S., Galat, V., Galat4, Y., Lee, Y. K. A., Wainwright, D., & Wu, J. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01014-w · Cited by 689
Jackson, H. J., Rafiq, S., & Brentjens, R. J. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.36 · Cited by 613
Moon, E. K., Carpenito, C., Sun, J., Wang, L.-C. S., Kapoor, V., Predina, J., Powell, D. J., Riley, J. L., June, C. H., & Albelda, S. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0351 · Cited by 537
Malignant Pleural Mesothelioma
Tsao, A. S., Wistuba, I., Roth, J. A., & Kindler, H. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8523 · Cited by 481
Metadata
- Authors
- Hassan, R., & Ho, M.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 44
- Issue
- 1
- Pages
- 46-53
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2008188798
- Cited by
- 340
- References
- 34
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
